Allergan Receives UR- Credit Rating from Morningstar (AGN)
Allergan (NYSE:AGN) has been given an “UR-” credit rating by Morningstar. . They also issued a negative credit outlook for the company and gave their stock a three star rating.
A number of other analysts have also recently weighed in on AGN. Analysts at Leerink Swann upgraded shares of Allergan from a “market perform” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $184.00 price target on the stock. Separately, analysts at Zacks reiterated an “outperform” rating on shares of Allergan in a research note on Tuesday, July 22nd. They now have a $205.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Allergan in a research note on Tuesday, July 22nd. They now have a $200.00 price target on the stock, up previously from $190.00. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and twelve have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $161.83.
Shares of Allergan (NYSE:AGN) traded up 0.97% during mid-day trading on Monday, hitting $163.68. 846,966 shares of the company’s stock traded hands. Allergan has a 52 week low of $86.95 and a 52 week high of $174.49. The stock’s 50-day moving average is $163.4 and its 200-day moving average is $151.2. The company has a market cap of $48.643 billion and a price-to-earnings ratio of 38.13.
Allergan (NYSE:AGN) last released its earnings data on Monday, July 21st. The company reported $1.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.44 by $0.07. The company had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the company posted $1.22 earnings per share. The company’s revenue for the quarter was up 16.7% on a year-over-year basis. Analysts expect that Allergan will post $5.80 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, September 5th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.12%. The ex-dividend date is Wednesday, August 13th.
Allergan, Inc is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products.
To view more credit ratings from Morningstar, visit www.morningstar.com.
Receive News & Ratings for Allergan Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.